1-3 of 3
Qui Tran
Close
Sort by
Journal Articles

Efficacy and Safety of Blinatumomab in Asian Adults with Relapsed/Refractory B-Precursor ALL

Yukio Kobayashi, Iekuni Oh, MD PhD, Toshihiro Miyamoto, MD PhD, Won-Sik Lee, Hiroatsu Iida, MD PhD, Hironobu Minami, MD PhD, Yoshinobu Maeda, MD PhD, Jun Ho Jang, Sung-Soo Yoon, MD PhD, Su-Peng Yeh, MD, Qui Tran, Joan Morris, Janet L. Franklin, Ka-Wing Chong, Hitoshi Kiyoi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5069.
https://doi.org/10.1182/blood-2019-124582
Published: 2019
Journal Articles

Health-Related Quality of Life in Adults with B-Cell Precursor Acute Lymphoblastic Leukemia and Minimal Residual Disease Treated with Blinatumomab

Ralf C Bargou, Gerhard Zugmaier, Massimiliano Bonifacio, Carlos Graux, Christoph Faul, MD, Max S. Topp, Qui Tran, Xinke Zhang, Nicola Goekbuget, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1377.
https://doi.org/10.1182/blood-2018-99-112259
Published: 2018
Journal Articles

Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab

Clinical Trials & Observations
Max S. Topp, Zachary Zimmerman, Paul Cannell, Hervé Dombret, Johan Maertens, Anthony Stein, Janet Franklin, Qui Tran, Ze Cong, Andre C. Schuh
Journal: Blood
Blood (2018) 131 (26): 2906–2914.
https://doi.org/10.1182/blood-2017-09-804658
Published: 2018
Includes: Supplemental data